Genesis Medical Interventional Inc. developed the F.A.S.T. Funnel Catheter line of proximal occlusion funnel catheters for embolic protection.

August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus-eluting coronary stent for the treatment of acute myocardial infarction (AMI).

CE mark approval means the product has been deemed safe and effective for treatment of AMI and can now be promoted for this indication in all member states of the European Union (EU), European Economic Area and Switzerland.

August 27, 2008 - The Children's Hospital at Montefiore (CHAM) in the Bronx recently received approval as a pediatric heart transplant center by the New York State Department of Health.

On the strength of a newly recruited pediatric cardiology team, specialists at CHAM can now treat any congenital or acquired heart abnormality in children and adolescents.

August 27, 2008 - XDx Inc. said today it received market clearance from the FDA for AlloMap Molecular Expression Testing, a noninvasive, multi-gene molecular diagnostics blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing.

XDx is the first U.S. molecular diagnostics company to obtain FDA clearance of an in vitro diagnostic multivariate index assay (IVDMIA) for use in transplant management.

Aug. 27, 2008 — Electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) was 99 percent as effective in ruling out obstructive coronary artery stenosis as the more expensive and invasive coronary angiography traditionally used by physicians, according to a multi-center study on the accuracy of cardiac imaging technology.

August 27, 2008 - Stereotaxis Inc. announced yesterday the FDA clearance of its magnetically tipped PowerAssert radiofrequency (RF) guidewire to cross chronic total occlusions (CTOs) in the peripheral vasculature.
Occluded or blocked arteries occur in patients with advanced peripheral arterial disease (PAD), and if left untreated can result in ulcerations and gangrene as well as significantly increased risk of limb loss and death. Eight to twelve million people have PAD, according to the American Heart Association.

Stentys, a French-based company, will feature its bifurcated stent at TCT 2008.

Terumo Interventional Systems will feature its Runthrough NS coronary guidewire at TCT 2008.

The Runthrough NS reportedly features exceptional tip shape retention, excellent guide and device support and aids vessel selection and lesion crossing. It also features DuoCore Technology and allows for multi-vessel procedures with one wire.

Terumo will also feature its line of peripheral (0.032 – 0.038-inch) and small vessel (0.018-0.025-inch) guidewires.

ProSolv CardioVascular, a FUJIFILM company, recently released ProSolv CardioVascular 4.0, a new software release featuring a Web-based application for full viewing and reporting capabilities using Web communication protocols, secured via SSL, in addition to a Web URL single-click application download and installation for easier deployment.

Other enhancements include new advanced clinical tools to further aid the diagnostic process, and the full integration to FUJIFILM Medical Systems’ Synapse PACS.

August 26, 2008 - Corgenix Medical Corp. announced its collaboration with BG Medicine whereby Corgenix' AtherOx products will be included in studies conducted by BG Medicine to predict near-term risk of first myocardial infarction (MI).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now